Analysis of mutations causing steroid 21-hydroxylase deficiency

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Congenital adrenal hyperplasia (CAH) is a group of inherited genetic disorders.
• Steroid 21-hydroxylase deficiency is the most common form of CAH, impairing cortisol synthesis.
• Understanding the genetic basis of CYP21B mutations is crucial for diagnosing and managing CAH.

Purpose of the Study:

• To characterize the mutations responsible for steroid 21-hydroxylase deficiency.
• To investigate the role of gene conversion in the etiology of CYP21B mutations.
• To correlate specific mutations with disease severity in congenital adrenal hyperplasia.

Main Methods:

• DNA hybridization analysis using cDNA and oligonucleotide probes.
• Cloning and sequencing of mutant 21-hydroxylase (CYP21B) genes.
• Analysis of patient DNA samples to identify deletion and non-deletional mutations.

Main Results:

• Approximately 20% of mutant alleles involve a 30 kb deletion encompassing parts of CYP21A, C4B, and CYP21B.
• Non-deletional mutations include a nonsense mutation (codon 318) for severe disease and missense mutations (codons 172, 281) for milder forms.
• Evidence suggests gene conversion events transferring mutations from the CYP21A pseudogene to CYP21B are prevalent.

Conclusions:

• Recombination between CYP21A and CYP21B is the predominant mechanism leading to 21-hydroxylase deficiency alleles.
• Specific mutations in CYP21B correlate with the clinical spectrum of congenital adrenal hyperplasia.
• Genetic characterization provides insight into the molecular pathogenesis of this inherited endocrine disorder.